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Background/Purpose: Several studies have reported that carotid endarterectomy (CEA) with patch angioplasty produces
superior results compared with primary closure. Conventional polytetrafluoroethylene (PTFE) patching has been shown
to have results comparable to autogenous vein patching; however, it requires a prolonged hemostasis time. Therefore,
many surgeons use collagen-impregnated Dacron patching (Hemashield [HP]). Recently, we reported a satisfactory
hemostasis time using the new hemostatic PTFE patch (ACUSEAL by Gore). This study is the first prospective
randomized trial comparing the ACUSEAL patch with the HP Finesse patch.
Methods: 200 CEAs were 1:1 randomized into two patch closure groups (ACUSEAL or Finesse). All patients underwent
immediate and 1 month postoperative duplex ultrasound studies. Demographic and clinical characteristics were similar
in both groups, including the mean operative diameter of the internal carotid artery and length of arteriotomy.
Results: The overall perioperative ipsilateral stroke rate was 2% (2% ACUSEAL, 2% Finesse; P  1.0). The perioperative
ipsilateral TIA rates were 0% for the ACUSEAL and 2% for the Finesse patch (P  .5). The combined perioperative
neurological event (TIA  stroke) rates were 2% for ACUSEAL and 4% for the Finesse (P  .68). The early >50%
restenosis rate was 0% for ACUSEAL vs 4% for Finesse patching. Two perioperative carotid thromboses were noted with
Finesse patching vs none with ACUSEAL patching (P .50). The combined early morbidity rate (TIA, stroke, and>50%
restenosis or thrombosis) was 2% for the ACUSEAL patch vs 8% for the Finesse patch (P  .10). The mean hemostasis
time for the ACUSEAL and Finesse patches was 5.1 vs 3.7 minutes (P  .01), however, the mean operative times were
similar for both groups (P  .61).
Conclusion: The perioperative neurological events and overall short-term morbidity associated with CEA when using
ACUSEAL or Finesse patches were similar. Both patches have short hemostasis times. ( J Vasc Surg 2007;45:881-4.)Over the past several years, we have published several
prospective studies concerning closure methods for carotid
endarterectomy (CEA). Results from these studies revealed
the benefits of patching compared with primary closure and
superior results with PTFE compared with collagen-
impregnated Dacron Hemashield synthetic patches (fewer
neurologic events, less early and late restenosis).1-3 Our
work raised concerns about the thrombogenic nature of the
conventional collagen-impregnated Hemashield patches,
with a significant risk of carotid thrombosis following re-
pair, however, significantly prolonged bleeding was seen
with the conventional PTFE patch.2,3
Hence, when a new patch was made available by W.L
Gore (ACUSEAL), with an improved design that reduced
needle hole bleeding time, we changed our preference to
this patch. We have reported the only prospective work
using the ACUSEAL patch, showing bleeding times similar
to historic results of the Dacron patch at 3 minutes.4 At the
same time that the ACUSEAL became available, a new
collagen-impregnated Dacron patch was also released (Fi-
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We report the early results from a prospective, randomized
trial comparing these two commercially available patches
used during carotid endarterectomy.
PATIENT POPULATION AND METHODS
Between August, 2003 and October, 2005, 200 ca-
rotid endarterectomies (200 patients) were randomized
into two groups using either the ACUSEAL polytetrafluo-
roethylene (PTFE) patching (W. L. Gore & Associates,
Flagstaff, Ariz) or the Finesse collagen-impregnated Da-
cron patching (Boston Scientific Corp, Natick, Mass). Us-
ing sealed opaque envelopes, each containing a slip of paper
with the patch assignment, patients were randomized in a
1:1 ratio. The randomization envelopes were generated in
blocks of 10 and placed in closed containers. After induc-
tion of anesthesia, but prior to skin incision, an envelope
was pulled from the container by the study controller and
opened, and the surgeon was notified of the patch selec-
tion. This study was approved by the Institutional Review
Board of Charleston Area Medical Center, Robert C. Byrd
Health Sciences Center of West Virginia University. Pa-
tients excluded from this study included those undergoing
CEA with concomitant coronary artery bypass grafting
(three patients), and redo CEA (two patients).
Prior to CEA, all patients underwent carotid color
duplex ultrasound imaging and/or magnetic resonance
angiography as a means of determining preoperative steno-
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were also tested. Preoperative risk factors including hyper-
tension, tobacco use status, diabetes mellitus, coronary
artery disease, and any preoperative use of antiplatelet
therapy were recorded. Indications for surgery were cate-
gorized into hemispheric transient ischemic attacks (TIA),
amaurosis fugax, hemispheric strokes, nonhemispheric
TIAs, and asymptomatic carotid stenoses of 70%.
Operative technique. All CEAs were done using gen-
eral anesthesia with systemic heparin and routine shunting
with a carotid Argyle shunt (C. R. Bard, Billerica, Mass).
No protamine was given at the end of the procedure. At the
time of the operation, the normal internal carotid artery
distal to the lesion was measured in millimeters using
calipers. The CEA was extended proximally and distally
beyond grossly diseased intima. All ACUSEAL PTFE
patches (8 mm wide, 0.5 mm thick) used were sutured
using 6-0 Prolene sutures (Prolene, Ethicon, Summerville,
NJ).5 The Finesse Hemashield patches (8 mm wide, 0.4
mm thick) were sutured with 6-0 Prolene sutures. Dextran-
40 was given intravenously (25cc/hour) beginning at the
time of endarterectomy and continuing for 24 hours. After
completion of patching and release of the carotid clamps,
and if no suture bleeding points were noted, the hemostasis
time was recorded as zero. If bleeding points were noted,
thrombin-soaked oxidized cellulose and digital pressure
were applied to stop any bleeding points before closure.
Hemostasis was checked after 3 minutes, and, if necessary,
in 2 minute increments. Operative and hemostasis times
were recorded. All procedures were drained for 24 hours
and all patients were started on an aspirin regimen (325 mg
daily) within 24 hours of their surgery.
Postoperative surveillance protocol. All patients un-
derwent immediate postoperative color duplex ultrasound
scanning (CDUS) (in the operating room if machine was
available, otherwise within 24 hours) using an ATL HDI
5000 system (Advanced Technology Laboratory, Phillips,
Bellevue, Wash), clinical observation, and examination by a
physician who was blinded to the type of patch. CDUS was
then repeated at 30 days. Duplex scanning was performed
to assess the presence of any residual and/or early resteno-
sis. Peak systolic velocities 140 cm/sec with spectral
broadening throughout systole and an increased diastolic
frequency were considered consistent with 50% stenosis.5
Statistical methods. All statistical analyses were per-
formed using SAS version 8.02 (SAS Inc, Cary, NC). Data
were analyzed based on the intent to treat. Continuous
variables (such as operative time, hemostasis time, and
vessel diameter) were compared using two-tailed Student
t-tests for independent measures and are represented as
mean  standard deviation. Morbidity rates and other
categorical variables were analyzed with either the 2 or
Fisher exact test, as appropriate. A P value less than .05 was
considered to represent statistical significance.
RESULTS
Indications for surgery, demographic, and clinical char-
acteristics were comparable between the patch groups (Ta-ble I). Table II summarizes the perioperative data for both
patches. As shown, the mean internal carotid artery diam-
eter and the length of arteriotomy were comparable for
both groups. The hemostasis time was significantly longer
for the ACUSEAL patch (5.17 vs 3.73 minutes, P  .01),
however, the operative time from skin to skin was compa-
rable for the two patches (97 vs 96 minutes, P  .61). No
patients in either group suffered postoperative hematoma
Table I. Demographic and preoperative data by patch
ACCUSEAL Finesse P-Value
Number of CEA (N) 100 100
Female 53 48
0.48Male 47 52
Age (years) 67.7  11.1 68.1  10.1 0.80
Hypertension 91 86 0.27
Coronary artery
disease 46 43 0.67
Diabetes mellitus 31 26 0.43
Peripheral vascular
disease 12 14 0.67
Hyperlipidemia 68 61 0.30
Current tobacco use 30 35 0.45
Past tobacco use 40 35 0.47
Any preop
antiplatelet Rx 80 79 0.86
Preoperative aspirin 66 72 0.36
Preoperative
clopidogrel 37 35 0.77
Preoperative total
cholesterol 179.9  40.5 187.8  37.7 0.15
Preoperative
triglycerides 223.2  153.8 223.0  169.7 0.99
Indications for CEA 0.78
Asymptomatic 45 (45.0) 45 (45.0) 1.0
Amaurosis fugax
and/or
hemispheric TIA 41 (41.0) 36 (36.0) 0.56
Stroke 8 (8.0) 11 (11.0) 0.63
Nonhemispheric TIA 6 (6.0) 8 (8.0) 0.78
Significance testing by either 2, Fisher exact, or two-tailed t-tests (with
F-tests for variance).
Table II. Perioperative data by patch
ACCUSEAL Finesse P-Value
Number of CEA (N) 100 100
Left side CEA 54 53
0.89Right side CEA 46 47
Stenosis of operated vessel 0.30
50%-59% 6 3 0.50
60%-69% 16 24 0.22
70%-99% 78 73 0.51
ICA diameter (mm) 5.3  0.8 5.5  1.0 0.35
Arteriotomy length (cm) 4.4  0.8 4.5  0.8 0.35
Skin to skin operative time
(mins) 97.4  23.7 95.9  18.7 0.61
Hemostasis time (mins) 5.17  5.2 3.73  2.7 0.01
Significance testing by either 2, Fisher exact, or two-tailed t-tests (with
F-tests for variance).requiring exploration.
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mortality for both patches. As noted, the perioperative
ipsilateral stroke rate was 2% in both patches. The overall
perioperative neurologic event (TIA/stroke) rate was 2%
for the ACUSEAL patches vs 4% for Finesse patches, how-
ever, this difference was not significant (P.68). There was
one perioperative death in the ACUSEAL patch group,
which was the same patient who suffered a stroke, whereas
the Finesse patch had 0% perioperative mortality. In the
two patients with ACUSEAL patching who suffered peri-
operative strokes, one was discovered in the operating
room, and the other occurred on postoperative day three.
The patient who had a neurologic deficit in the operating
room underwent immediate intraoperative angiogram, fol-
lowed by exploration with thrombectomy to remove what
was felt to be white clots and was repatched. The patient
recovered from her stroke in less than 1 week and had a
normal duplex exam at 30 days. The other patient had a
normal postoperative duplex ultrasound exam without re-
sidual stenosis, but suffered an embolic stroke that was
treated with heparin therapy, which led to a cerebral hem-
orrhage and death, 3 days postoperatively.
Two patients with Finesse patching had perioperative
minor strokes, one was noted in the recovery room and one
in the operating room. Both patients had normal postop-
erative carotid duplex ultrasounds and were treated with
antiplatelet therapy. Two other patients with Finesse patch-
ing had perioperative TIAs, one was noted in the recovery
room and had a normal carotid duplex ultrasound and was
treated with antiplatelet therapy; the other patient had a
TIA 2 weeks postoperatively with a normal carotid duplex
ultrasound and was also treated with antiplatelet therapy.
There were two patients in each group (n  4 total)
with residual stenosis of 50%, all of whom were asymp-
tomatic. The incidence of 50% restenosis at 30 days was
0% for the ACUSEAL patch vs 4% for the Finesse patch
(this included one patient with asymptomatic 50% to less
Table III. Morbidity and mortality data by patch
ACCUSEAL Finesse P-Value
Number of CEA (N) 100 100
Any perioperative neurological event 2 4 0.68
Stroke (ipsilateral) 2 2 1.0
TIA (ipsilateral) 0 2 0.5
Perioperative mortality 1* 0 1.00
Restenosis (50%) at 30-day U/S 0 4 0.12
50%-59% 0 1 1.0
60%-69% 0 0 1.0
70%-99% 0 1 1.0
Thrombosis 0 2 0.5
Combined perioperative neurological
events (TIA/stroke, 50%
restenosis, or carotid
thrombosis)† 2 8 0.1
*Patient is 1 of 2 with perioperative stroke. Significance testing by either 2,
Fisher exact or two-tailed t-tests (with F-tests for variance).
†Number of patients.than 60% stenosis, one patient with asymptomatic 70% toless than 99% stenosis, and two with asymptomatic periop-
erative carotid thrombosis, P .5, and both were noted at
30 days postoperatively).
The combined incidence of perioperative neurological
events (TIA/stroke) and 50% restenosis or carotid
thrombosis was 2% for the ACUSEAL patch vs 8% for the
Finesse patch (P  .10).
DISCUSSION
Recently, a systematic review of randomized controlled
trials comparing primary closure vs patching,6 concluded
that patch angioplasty decreases the risk of perioperative
death or stroke as well as long-term risk of ipsilateral
ischemic events. Despite this conclusion that routine patch-
ing should be recommended based on literature support,
the use of autologous vs prosthetic patching was unsettled.
Autologous tissue either by jugular vein or saphenous vein,
has shown good results.1,7 However, most institutions use
a synthetic patch for multiple reasons such as: eliminating
wound-related complications secondary to autologous vein
harvesting, leaving vein conduits intact and readily available
for potential future coronary or peripheral revasculariza-
tions, and reduced incidence of patch rupture and aneurys-
mal changes.8,9 Although infection of a carotid patch is a
feared complication, we did not see any patch infections in
this series.
Bleeding has been the Achilles heel of the PTFE patch.
In our previous comparison of conventional PTFE with
Hemashield, bleeding was significantly longer with a mean
hemostasis time of 14 minutes for PTFE compared with 3
minutes with the Hemashield patch.2 Hemostasis time in
the current series with the improved PTFE ACUSEAL
patch was 5minutes, which was similar to the 3minute time
reported in our recent report with this patch.4 Despite this
improved hemostasis time compared with the traditional
PTFE patch, the Finesse patch had a shorter hemostasis
time with a mean of three minutes, although most would
consider such a time difference clinically insignificant.
A criticism of our previous randomized study compar-
ing the conventional PTFE to the Hemashield was that we
used a PTFE suture (TT-9 needle, CV-6 suture) in the
PTFE group only.2 Hence, in the current series we used
6-0 Prolene sutures in both groups. The use of the PTFE
suture has been shown to reduce needle hole bleeding in
modified PTFE patch with a design of needle/suture diam-
eter ratio of 1:1.10,11
Overall comparison of perioperative neurological
events between the two patches did not demonstrate any
statistically significant differences. The overall neurological
event rate of the new modified PTFE patch was similar to
that found with conventional PTFE reported in our previ-
ous randomized trial. (2% vs 3%, respectively). However,
the Finesse patch produced better results than those previ-
ously achieved with the conventional Hemashield patch
(4% vs 12% respectively). Additionally, the number of pa-
tients with 50% stenosis at 30-day duplex exam was
reduced from 12% in the previous series to 4% using the
Finesse patch. The ACUSEALPTFE patch was comparable
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with duplex findings of 50% stenosis at 30 days in the
current series compared with our previous report of 2%.12
One concern with the use of the conventional Dacron-
Hemashield patches was the thrombogenic nature of this
patch, as five perioperative carotid thromboses occurred in
our previous experience. The Finesse patch was associated
with two perioperative carotid thromboses, compared with
none in the ACUSEAL patch group. However, this differ-
ence was not statistically significant. Long-term follow-up
will be needed to evaluate any potential differences in the
rate of late restenosis and thrombosis between the two
patches.
Overall, the results of this study show equally good
outcomes from both patches. There was no statistically
significant difference in deaths, stroke rates, TIA rates, or in
early restenosis. Although a significant difference did ap-
pear in the hemostatic time, it is probably a finding of
limited clinical significance.
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